The Department for International Trade (DIT), in partnership with the Parc Científic de Barcelona (PCB), is hosting a morning session of presentations where UK CRO specialists will cover key aspects involved in the successful delivery of pre-clinical development and the effective management of clinical trials. Domainex CSO, Dr Trevor Perrior will present:

Impact of a fragment-based approach to the discovery of new medicines.

If you would like to find out more about our fragment-based drug discovery or discuss how Domainex could support your drug discovery project, Trevor and COO, Dr Tom Mander would be happy to hear from you. 

If you would like to attend, please register for the event.